Suppr超能文献

采用茶包法快速平行合成具有生物活性的折叠环肽

Rapid parallel synthesis of bioactive folded cyclotides by using a tea-bag approach.

作者信息

Aboye Teshome, Kuang Yuting, Neamati Nouri, Camarero Julio A

机构信息

Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089-9121 (USA).

出版信息

Chembiochem. 2015 Mar 23;16(5):827-33. doi: 10.1002/cbic.201402691. Epub 2015 Feb 6.

Abstract

We report here the first rapid parallel production of bioactive folded cyclotides by using Fmoc-based solid-phase peptide synthesis in combination with a "tea-bag" approach. Using this approach, we efficiently synthesized 15 analogues of the CXCR4 antagonist cyclotide MCo-CVX-5c. Cyclotides were synthesized in a single-pot, cyclization/folding reaction in the presence of reduced glutathione. Natively folded cyclotides were quickly purified from the cyclization/folding crude mixture by activated thiol Sepharose-based chromatography. The different folded cyclotide analogues were then tested for their ability to inhibit the CXCR4 receptor in a cell-based assay. The results indicated that this approach can be used for the efficient chemical synthesis of libraries of cyclotides with improved biological properties that can be easily interfaced with solution or cell-based assays for rapid screening.

摘要

我们在此报告,通过使用基于芴甲氧羰基(Fmoc)的固相肽合成法并结合“茶包”方法,首次实现了生物活性折叠环肽的快速平行生产。采用这种方法,我们高效合成了15种趋化因子受体CXCR4拮抗剂环肽MCo-CVX-5c的类似物。环肽在还原型谷胱甘肽存在下于单锅中通过环化/折叠反应合成。通过基于活化硫醇琼脂糖凝胶的色谱法,可快速从环化/折叠粗混合物中纯化出天然折叠的环肽。然后,在基于细胞的测定中测试不同折叠环肽类似物抑制CXCR4受体的能力。结果表明,该方法可用于高效化学合成具有改善生物学特性的环肽文库,这些环肽可轻松与基于溶液或细胞的测定方法对接,以进行快速筛选。

相似文献

1
Rapid parallel synthesis of bioactive folded cyclotides by using a tea-bag approach.
Chembiochem. 2015 Mar 23;16(5):827-33. doi: 10.1002/cbic.201402691. Epub 2015 Feb 6.
2
In vivo Evaluation of an Engineered Cyclotide as Specific CXCR4 Imaging Reagent.
Chemistry. 2017 Oct 17;23(58):14469-14475. doi: 10.1002/chem.201702540. Epub 2017 Aug 3.
3
Lipidation of a bioactive cyclotide-based CXCR4 antagonist greatly improves its pharmacokinetic profile in vivo.
J Control Release. 2023 Jul;359:26-32. doi: 10.1016/j.jconrel.2023.05.026. Epub 2023 May 30.
4
Efficient Enzymatic Cyclization of Disulfide-Rich Peptides by Using Peptide Ligases.
Chembiochem. 2019 Jun 14;20(12):1524-1529. doi: 10.1002/cbic.201900033. Epub 2019 Apr 25.
5
Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1.
J Biol Chem. 2012 Nov 23;287(48):40493-501. doi: 10.1074/jbc.M112.395442. Epub 2012 Sep 25.
6
Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity.
J Med Chem. 2012 Dec 13;55(23):10729-34. doi: 10.1021/jm301468k. Epub 2012 Nov 27.
8
Chemical Synthesis and Functional Analysis of VarvA Cyclotide.
Molecules. 2018 Apr 19;23(4):952. doi: 10.3390/molecules23040952.
9
Circular Permutation of the Native Enzyme-Mediated Cyclization Position in Cyclotides.
ACS Chem Biol. 2020 Apr 17;15(4):962-969. doi: 10.1021/acschembio.9b00996. Epub 2020 Mar 30.
10
Optimal oxidative folding of the novel antimicrobial cyclotide from Hedyotis biflora requires high alcohol concentrations.
Biochemistry. 2011 Aug 23;50(33):7275-83. doi: 10.1021/bi2007004. Epub 2011 Jul 25.

引用本文的文献

1
Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics.
Chem Rev. 2024 Nov 27;124(22):13020-13093. doi: 10.1021/acs.chemrev.4c00423. Epub 2024 Nov 14.
2
Resistance is futile: targeting multidrug-resistant bacteria with Cys-rich cyclic polypeptides.
RSC Chem Biol. 2023 Aug 21;4(10):722-735. doi: 10.1039/d3cb00015j. eCollection 2023 Oct 4.
3
Lipidation of a bioactive cyclotide-based CXCR4 antagonist greatly improves its pharmacokinetic profile in vivo.
J Control Release. 2023 Jul;359:26-32. doi: 10.1016/j.jconrel.2023.05.026. Epub 2023 May 30.
4
Insights into the synthesis strategies of plant-derived cyclotides.
Amino Acids. 2023 Jun;55(6):713-729. doi: 10.1007/s00726-023-03271-8. Epub 2023 May 4.
5
Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development.
Molecules. 2022 Sep 29;27(19):6430. doi: 10.3390/molecules27196430.
6
Engineered Cyclotides with Potent Broad in Vitro and in Vivo Antimicrobial Activity.
Chemistry. 2021 Sep 1;27(49):12702-12708. doi: 10.1002/chem.202101438. Epub 2021 Aug 6.
7
The Potential of the Cyclotide Scaffold for Drug Development.
Biomedicines. 2019 Apr 19;7(2):31. doi: 10.3390/biomedicines7020031.
9
Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications.
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5089-5099. doi: 10.1016/j.bmcl.2017.10.051. Epub 2017 Oct 21.
10
In vivo Evaluation of an Engineered Cyclotide as Specific CXCR4 Imaging Reagent.
Chemistry. 2017 Oct 17;23(58):14469-14475. doi: 10.1002/chem.201702540. Epub 2017 Aug 3.

本文引用的文献

1
Butelase 1 is an Asx-specific ligase enabling peptide macrocyclization and synthesis.
Nat Chem Biol. 2014 Sep;10(9):732-8. doi: 10.1038/nchembio.1586. Epub 2014 Jul 20.
2
Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.
Eur J Med Chem. 2014 Dec 17;88:10-8. doi: 10.1016/j.ejmech.2014.06.047. Epub 2014 Jun 24.
3
Structural insights into the role of the cyclic backbone in a squash trypsin inhibitor.
J Biol Chem. 2013 Dec 13;288(50):36141-8. doi: 10.1074/jbc.M113.528240. Epub 2013 Oct 29.
4
In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide.
J Am Chem Soc. 2013 Aug 7;135(31):11623-11633. doi: 10.1021/ja405108p. Epub 2013 Jul 25.
5
Expression of fluorescent cyclotides using protein trans-splicing for easy monitoring of cyclotide-protein interactions.
Angew Chem Int Ed Engl. 2013 Mar 11;52(11):3126-31. doi: 10.1002/anie.201209219. Epub 2013 Jan 15.
6
Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity.
J Med Chem. 2012 Dec 13;55(23):10729-34. doi: 10.1021/jm301468k. Epub 2012 Nov 27.
7
Cyclic peptides arising by evolutionary parallelism via asparaginyl-endopeptidase-mediated biosynthesis.
Plant Cell. 2012 Jul;24(7):2765-78. doi: 10.1105/tpc.112.099085. Epub 2012 Jul 20.
8
Cyclotides associate with leaf vasculature and are the products of a novel precursor in petunia (Solanaceae).
J Biol Chem. 2012 Aug 3;287(32):27033-46. doi: 10.1074/jbc.M112.370841. Epub 2012 Jun 14.
9
Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment.
Angew Chem Int Ed Engl. 2012 Jun 4;51(23):5620-4. doi: 10.1002/anie.201200984. Epub 2012 Apr 24.
10
Efficient one-pot cyclization/folding of Rhesus θ-defensin-1 (RTD-1).
Bioorg Med Chem Lett. 2012 Apr 15;22(8):2823-6. doi: 10.1016/j.bmcl.2012.02.080. Epub 2012 Mar 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验